People In Brief
This article was originally published in The Gray Sheet
Executive Summary
FDA Deputy Commissioner for Policy: Amit Sachdev leaves the agency to pursue private-sector opportunities after serving more than eight years in various government positions and roughly a year at one of the three deputy-commissioner posts created by Acting Commissioner Lester Crawford in the top-level restructuring that followed Mark McClellan's 2004 departure. As FDA's legislative liaison, Sachdev was involved with MDUFMA (1"The Gray Sheet" Sept. 23, 2002, p. 4). Crawford's confirmation as FDA's permanent chief could create another opportunity to revisit its leadership structure...
You may also be interested in...
Device Accessibility Complaints To Be Monitored By CMS Ombudsman
CMS ombudsman Dan Schreiner will report annually to Congress on the agency's performance in addressing beneficiary concerns, as stipulated by the Medicare Modernization Act (MMA)
Device Accessibility Complaints To Be Monitored By CMS Ombudsman
CMS ombudsman Dan Schreiner will report annually to Congress on the agency's performance in addressing beneficiary concerns, as stipulated by the Medicare Modernization Act (MMA)
Align v. OrthoClear: Injunction Bars Sales Rep Poaching, Info Disclosure
A recent court order restrains teeth straightening device start-up OrthoClear from recruiting sales reps from Align Technology in anticipation of a spring launch of its OrthoClear System